Depo-Provera Brain Tumor Risk Lawsuits

A recent 2024 medical study revealed a potential connection between the use of Depo-Provera, a widely used birth control shot, and a type of brain tumor called meningioma. The research suggests that women who used Depo-Provera, or any other generic versions of this injectable contraceptive, were at a heightened risk of developing meningiomas. Using this form of birth control increases the risk of developing a brain tumor over time. However, the makers of Depo-Provera, Pfizer, did not disclose this knowledge to users or medical providers, which is why the women affected are taking legal action. 

A healthcare provider injects the Depo-Provera birth control shot into the deltoid muscle or buttocks every three months. This method effectively prevents pregnancy by using the synthetic hormone medroxyprogesterone acetate to thicken cervical mucus and thin the uterine lining, stopping ovulation in the process. 

Researchers believe that the hormone in Depo-Provera, medroxyprogesterone acetate, stimulates tumor growth in the tissue layers surrounding the brain and spinal cord. These tumors, called meningiomas, are typically non-cancerous but can lead to a series of health issues, including headaches, memory loss, hearing loss, changes in vision, loss of smell, weakness in the arms or legs, and seizures. When a person’s nervous system is affected by meningiomas, doctors must perform surgery to remove the tumor, which carries its own set of risks.

If you currently receive Depo-Provera injections or have received birth control shots in the past and have been diagnosed with a meningioma brain tumor, contact our Depo-Provera Lawsuit Lawyers at Whittel & Melton for a free consultation. We can meet with you for free and discuss your eligibility for filing a claim. 

Who Qualifies for a Depo-Provera Lawsuit? 

Our Depo-Provera Brain Tumor Lawsuit Lawyers at Whittel & Melton are currently investigating claims for women who meet the following criteria: 

• You must receive at least two injections of the Depo-Provera birth control shot or another generic form of this injectable contraceptive that your doctor prescribes to you.
• You need to have received injections of Depo-Provera or its generic version after 1992.
• You must receive a medical diagnosis confirming a benign or malignant meningioma tumor.

If you meet these criteria, we urge you to contact our lawyers immediately. Time constraints may affect how long you have to file a claim, so schedule your free consultation with us now. 

The Risks of Using Depo-Provera Were Not Disclosed

A study published by The British Medical Journal in March 2024 sparked the Depo-Provera brain tumor litigation process. The study discovered that women who used Depo-Provera were 5.6 times more likely to develop meningiomas than those who used other forms of hormonal birth control. Long-term users of the Depo-Provera shot experience a higher prevalence of meningioma development.

The plaintiffs involved in the lawsuits currently filed claim that many women would have selected alternative forms of birth control and medical professionals would have been more cautious when prescribing the birth control shot if Pfizer, the manufacturer of the drug, had revealed this information. 

Timeline of Depo-Provera Brain Tumor Lawsuits

March 2024: Study published in The British Medical Journal proposing a link between women who routinely received the Depo-Provera shot and developing meningioma brain tumors. The study highlighted the importance of further research on this matter. 

March 2024: Pfizer, the manufacturer of Depo-Provera, acknowledged the dangers associated with long-term use of progestogens and announced that it would update its product labels with this information.

August 2024: Lawyers begin investigating brain tumor claims. 

October 2024: The first lawsuit filed in California claimed that Pfizer and its related companies were aware of the increased risk of brain tumors but did not issue a warning. 

November 2024: More plaintiffs have filed lawsuits. The lawsuits are ongoing, and they filed a motion to consolidate them into a single MDL (multidistrict litigation). Courts typically form an MDL when 25 or more linked cases in several federal jurisdictions address shared problems and include similar defendants.

December 2024: Twenty-two federal Depo-Provera meningioma lawsuits are on file in California, and additional lawsuits are pending in Nevada, Indiana, Massachusetts, and Missouri. The lawsuits involving Depo-Provera and meningiomas are currently ongoing, and no large-scale settlement program has emerged. A mass tort or multidistrict litigation (MDL) might eventually combine the claims, speeding up the settlement process and resulting in larger payouts.

File Your Depo-Provera Case With Us Today 

Our experienced team of medical product liability lawyers has the knowledge and experience to assist you in determining whether you are eligible to pursue a Depo-Provera case. If you are entitled to financial compensation, we will file a claim.

Call us today at 866-608-5529 or contact us online for a free consultation to learn more about how we can guide you through the litigation process.